🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/07/1986 | 5,44 | 5,50 | 5,38 | 5,41 | +0,24% | 2,19% | 13.900.882 |
| 17/07/1986 | 5,26 | 5,41 | 5,26 | 5,39 | +2,91% | 2,90% | 9.039.629 |
| 16/07/1986 | 5,25 | 5,27 | 5,22 | 5,24 | +0,13% | 1,01% | 6.076.094 |
| 15/07/1986 | 5,22 | 5,27 | 5,17 | 5,23 | +0,25% | 2,03% | 10.575.158 |
| 14/07/1986 | 5,25 | 5,29 | 5,22 | 5,22 | -1,87% | 1,26% | 4.980.096 |
| 11/07/1986 | 5,29 | 5,37 | 5,27 | 5,32 | +0,63% | 1,88% | 5.442.264 |
| 10/07/1986 | 5,28 | 5,29 | 5,20 | 5,29 | +0,12% | 1,76% | 7.177.752 |
| 09/07/1986 | 5,28 | 5,29 | 5,23 | 5,28 | +0,13% | 1,13% | 5.163.077 |
| 08/07/1986 | 5,27 | 5,29 | 5,06 | 5,27 | -1,73% | 4,27% | 6.813.677 |
| 07/07/1986 | 5,49 | 5,49 | 5,31 | 5,37 | -2,29% | 3,14% | 5.625.245 |
| 03/07/1986 | 5,58 | 5,58 | 5,46 | 5,49 | -1,66% | 2,14% | 4.217.990 |
| 02/07/1986 | 5,60 | 5,61 | 5,55 | 5,59 | -0,24% | 1,06% | 3.431.362 |
| 01/07/1986 | 5,49 | 5,60 | 5,49 | 5,60 | +1,08% | 2,05% | 4.766.933 |
| 30/06/1986 | 5,51 | 5,61 | 5,50 | 5,54 | +1,09% | 2,04% | 5.781.816 |
| 27/06/1986 | 5,43 | 5,50 | 5,41 | 5,48 | +1,22% | 1,59% | 5.008.392 |
| 26/06/1986 | 5,38 | 5,43 | 5,31 | 5,41 | +0,49% | 2,34% | 3.991.622 |
| 25/06/1986 | 5,39 | 5,45 | 5,37 | 5,39 | -0,25% | 1,60% | 5.246.078 |
| 24/06/1986 | 5,43 | 5,47 | 5,37 | 5,40 | -0,12% | 1,95% | 4.559.429 |
| 23/06/1986 | 5,42 | 5,49 | 5,38 | 5,41 | -0,49% | 1,96% | 3.852.029 |
| 20/06/1986 | 5,45 | 5,45 | 5,29 | 5,43 | +0,74% | 3,04% | 8.932.104 |
| 19/06/1986 | 5,42 | 5,54 | 5,39 | 5,39 | -0,49% | 2,69% | 11.401.402 |
| 18/06/1986 | 5,34 | 5,45 | 5,33 | 5,42 | +2,25% | 2,36% | 9.624.413 |
| 17/06/1986 | 5,30 | 5,31 | 5,25 | 5,30 | +0,63% | 1,13% | 5.919.523 |
| 16/06/1986 | 5,25 | 5,33 | 5,24 | 5,27 | +0,76% | 1,64% | 6.587.309 |
| 13/06/1986 | 5,12 | 5,29 | 5,10 | 5,23 | +4,23% | 3,63% | 7.117.387 |
| 12/06/1986 | 5,08 | 5,11 | 4,88 | 5,02 | -1,43% | 4,57% | 6.172.301 |
| 11/06/1986 | 5,12 | 5,12 | 5,02 | 5,09 | -0,26% | 1,94% | 3.825.619 |
| 10/06/1986 | 5,10 | 5,13 | 5,10 | 5,10 | -0,13% | 0,52% | 5.555.448 |
| 09/06/1986 | 5,16 | 5,16 | 5,10 | 5,11 | -2,16% | 1,03% | 4.915.958 |
| 06/06/1986 | 5,22 | 5,29 | 5,20 | 5,22 | +1,03% | 1,78% | 8.690.645 |